Inhaled Granulocyte/Macrophage–Colony Stimulating Factor as Therapy for Pulmonary Alveolar Proteinosis

Rationale: Inhaled granulocyte/macrophage–colony stimulating factor (GM-CSF) is a promising therapy for pulmonary alveolar proteinosis (PAP) but has not been adequately studied. Objectives: To evaluate safety and efficacy of inhaled GM-CSF in patients with unremitting or progressive PAP. Methods: We...

詳細記述

保存先:
書誌詳細
主要な著者: Tazawa, Ryushi, Trapnell, Bruce C., Inoue, Yoshikazu, Arai, Toru, Takada, Toshinori, Nasuhara, Yasuyuki, Hizawa, Nobuyuki, Kasahara, Yasunori, Tatsumi, Koichiro, Hojo, Masayuki, Ishii, Haruyuki, Yokoba, Masanori, Tanaka, Naohiko, Yamaguchi, Etsuro, Eda, Ryosuke, Tsuchihashi, Yoshiko, Morimoto, Konosuke, Akira, Masanori, Terada, Masaki, Otsuka, Junji, Ebina, Masahito, Kaneko, Chinatsu, Nukiwa, Toshihiro, Krischer, Jeffrey P., Akazawa, Kohei, Nakata, Koh
フォーマット: Artigo
言語:Inglês
出版事項: American Thoracic Society 2010
主題:
C. Critical Care
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2894410/
https://ncbi.nlm.nih.gov/pubmed/20167854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.200906-0978OC
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料